BAKER DOUGLAS P 4
4 · OptimizeRx Corp · Filed Oct 5, 2021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-10-05$84.22/sh−4,000$336,880→ 34,796 total - Exercise/Conversion
Common Stock
2021-10-05$7.51/sh+10,000$75,100→ 44,796 total - Sale
Common Stock (pursuant to 10B5-1 plan)
2021-10-05$82.35/sh−10,000$823,500→ 34,796 total - Exercise/Conversion
Stock Option
2021-10-05$7.51/sh−10,000$75,100→ 34,699 totalExercise: $7.51From: 2020-06-30Exp: 2025-03-11→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.